capacity for targeted 22 Nanopharmaceutical Advanced Delivery Systems delivery of the chemotherapy drug 10-hydroxycamptothecin. Int. J. Pharm., 465, 378–387, 2014.
21. Tila, D., Ghasemi, S., Yazdani-Arazi, S.N., Ghanbarzadeh, S., Functional liposomes in the cancer-targeted drug delivery. J. Biomater. Appl., 30, 3–16, 2015.
22. Deamer, D.W., From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921-2010. FASEB J., 24, 1308–1310, 2010.
23. Swaminathan, J. and Ehrhardt, C., Liposomal delivery of proteins and peptides. Expert Opin. Drug Deliv., 9, 1489–1503, 2012.
24. Garg, T.K. and Goyal, A., Liposomes: targeted and controlled delivery system. Drug Deliv., 4, 62–71, 2014.
25. Xing, H., Hwang, K., Lu, Y., Recent Developments of Liposomes as Nanocarriers for theranostic applications. Theranostic, 6, 1336–1352, 2016.
26. Blume, G. and Cevc, G., Molecular mechanism of lipid vesicles longevity in-vivo. Biochim. Biophys. Acta, 1146, 157–168, 1993.
27. Allen, T.M. and Cullis, P.R., Liposomal drug delivery system from concept to clinical applications. Adv. Drug Deliv., 65, 36–48, 2013.
28. Kaneda, Y., Virosomes: evolution of the liposome as a targeted drug delivery system. Adv. Drug Deliv. Rev., 43, 197–205, 2000.
29. Samad, A., Sultana, Y., Aqil, M., Liposomal drug delivery systems: an update review. Curr. Drug Deliv., 4, 297–305, 2007.
30. Couvreur, P., Dubernet, C., Puisieux, F., Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur. J. Pharm. Biopharm., 41, 2–13, 1995.
31. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E., Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release, 70, 1–20, 2001.
32. Smith, A., Evaluation of poly (lactic acid) as a biodegradable drug delivery system for parenteral administration. Int. J. Pharm., 30, 215–220, 1986.
33. Muller, R.H., Mader, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm., 50, 1, 161–177, 2000.
34. Mehnert, W. and Mader, K., Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev., 47, 165–196, 2001.
35. Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., Lou, H., Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release, 133, 238–244, 2009.
36. Uner, M. and Yener, G., Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomedicine, 3, 289–300, 2007.
37. Harde, H., Das, M., Jain, S., Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin. Drug Deliv., 8, 1407–1424, 2011.
38. M.R. Gasco, Method for Producing Solid Lipid Microspheres Having a Narrow Size Distribution, US Patent-US5250236A, 1993.
39. Ochekpe, N.A., Olorunfemi, P.O., Ngwuluka, N.C., Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Trop. J. Pharm., 8, 275–287, 2009.
40. Khurana, S., Utreja, P., Tiwary, A., Jain, N., Jain, S., Nanostructured lipid carriers and their application in drug delivery. Int. J. Biomed. Eng. Technol., 2, 152–171, 2009.
41. Iqbal, M.A., Md, S., Sahni, J.K., Baboota, S., Dang, S., Ali, J., Nanostructured lipid carriers system: Recent advances in drug delivery. J. Drug Targeting, 10, 813–830, 2012.
42. Ranpise, N.S., Korabu, S.S., Ghodake, V.N., Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf. B Biointerfaces, 116, 81–87, 2014.
43. Tiwari, R. and Pathak, K., Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int. J. Pharm., 415, 232–243, 2011.
44. Nanjwade, B.K., Patel, D.J., Udhani, R.A., Manvi., F.V., Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs. Sci. Pharm., 79, 705–727, 2011.
45. Tamjidi, F., Shahedi, M., Varshosaz, J., Nasirpour, A., Nanostructured lipid carriers (NLC): a potential delivery system for bioactive food molecules. Innov. Food Sci. Emerg. Technol., 19, 29–43, 2013.
46. Chime, S., Kenechukwu, F., Attama, A., Nanoemulsions-advances in formulation, characterization and applications in drug delivery, in: Application of Nanotechnology in Drug Delivery, A.D. Sezer (Ed.), pp. 77–11, IntechOpen Limited, London, 2014.
47. Jaiswal., M., Dudhe, R., Sharma, P., Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech, 5, 123–127, 2015.
48. Thiagarajan, P., Nanoemulsion for drug delivery through different routes. Res. Biotechnol., 2, 1–13, 2011.
49. Lovelyn, C. and Attama, A.A., Current State of Nanoemulsions in Drug Delivery. J. Biomater. Nanobiotechnol., 2, 626–639, 2011.
50. Pande, S.V. and Biyani, K.R., Microencapsulation by solvent evaporation method of BCS Class 4 drugs for bioavailability enhancement. J. Drug Deliv. Ther., 6, 18–30, 2016.
51. Mundhe, A.V., Fuloria, N.K., Biyani, K.R., Cocrystallization: an alternative approach for solid modification. J. Drug Deliv. Ther., 3, 166–172, 2013.
52. Shelke, P.V., Dumbare, A.S., Gadhave, M.V., Jadhav, S.L., Sonawane, A.A., Gaikwad, D.D., Formulation and evaluation of rapidly dis integrating film of amlodipine besylate. J. Drug Deliv. Ther., 2, 72–75, 2012.
53. Maurya, S.D., Arya, R.K.K., Rajpal, G., Dhakar, R.C., Self-micro emulsifying drug delivery systems (SMEDDs): A review on physico-chemical and biopharmaceutical aspects. J. Drug Deliv. Ther., 7, 55–65, 2017.
54. Agrawal, S., Giri, T.K., Tripathi, D.K., Ajazuddin, Alexander, A., A review on noval therapeutic strategies for the enhancement of solubility for hydrophobic drugs through lipid based Self Micro Emulsifying Drug Delivery System: A Novel Approach. Am. J. Drug Discov., 2, 143–183, 2012.
55. Gursoy, R.N. and Benita, S., Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother., 58, 173–182, 2004.
56. Wu, W., Wang, Y., Que, L., Enhanced bioavailability of silymarin by self-micro emulsifying drug delivery system. Eur. J. Pharm. Biopharm., 63, 288–294, 2006.
57. Kang, B.K., Lee, J.S., Chon, S.K., Jeong, S.Y., Yuk, S.H., Khang, G. et al., Development of self-micro emulsifying drug delivery systems (SMEDDs) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm., 274, 65–73, 2004.
58. Ishiwa, J., Sato, T., Mimaki, Y., Sashida, Y., Yano, M., Ito, A., A citrus flavonoid, nobiletin, suppresses production and gene expression of matrixmetalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. J. Rheumatol., 27, 20–25, 2000.
59. Lin, N., Sato, T., Takayama, Y., Mimaki, Y.,
